InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Evolus, Inc.

EOLS Clue Score45
United States Fiscal year ends December CIK 0001570562
$7.73 -0.90% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $7.73 +11.06% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 8 Feb 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Operating income−11.7Net income−4.5Fiscal year 2018Revenue0.0Operating income−46.1Net income−46.9Fiscal year 2019Revenue34.9Operating income−98.9Net income−90.0Fiscal year 2020Revenue56.5 +61.9%Operating income−153.1Net income−163.0EPS, diluted−4.83Fiscal year 2021Revenue99.7 +76.3%Operating income−44.4Net income−46.8EPS, diluted−0.94Fiscal year 2022Revenue148.6 +49.1%Operating income−65.3Net income−74.4EPS, diluted−1.33Fiscal year 2023Revenue202.1 +36.0%Operating income−49.2Net income−61.7EPS, diluted−1.08Fiscal year 2024Revenue266.3 +31.8%Operating income−34.4Net income−50.4EPS, diluted−0.81Fiscal year 2025Revenue297.2 +11.6%Operating income−32.7Net income−51.6EPS, diluted−0.80
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 0.0 34.9 56.5 99.7 148.6 202.1 266.3 297.2
Growth +61.9% +76.3% +49.1% +36.0% +31.8% +11.6%
Operating income −11.7 −46.1 −98.9 −153.1 −44.4 −65.3 −49.2 −34.4 −32.7
Net income −4.5 −46.9 −90.0 −163.0 −46.8 −74.4 −61.7 −50.4 −51.6
Growth
EPS, diluted n/a n/a n/a −4.83 −0.94 −1.33 −1.08 −0.81 −0.80
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Fiscal year 2018Fiscal year 2019Gross margin77.1%Operating margin−283.3%Net margin−257.8%Free cash flow margin−268.4%Fiscal year 2020Operating margin−270.7%Net margin−288.3%Free cash flow margin−103.8%Fiscal year 2021Operating margin−44.6%Net margin−47.0%Free cash flow margin−33.9%Fiscal year 2022Gross margin60.4%Operating margin−44.0%Net margin−50.1%Free cash flow margin−58.2%Fiscal year 2023Gross margin68.1%Operating margin−24.4%Net margin−30.5%Free cash flow margin−17.1%Fiscal year 2024Gross margin68.5%Operating margin−12.9%Net margin−18.9%Free cash flow margin−7.3%Fiscal year 2025Gross margin66.3%Operating margin−11.0%Net margin−17.4%Free cash flow margin−15.4%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a 77.1% n/a n/a 60.4% 68.1% 68.5% 66.3%
Operating margin n/a n/a −283.3% −270.7% −44.6% −44.0% −24.4% −12.9% −11.0%
Net margin n/a n/a −257.8% −288.3% −47.0% −50.1% −30.5% −18.9% −17.4%
Free cash flow margin n/a n/a −268.4% −103.8% −33.9% −58.2% −17.1% −7.3% −15.4%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−13.2Capital expenditure0.0Free cash flow−13.2Fiscal year 2018Operating cash flow−25.7Capital expenditure−0.0Free cash flow−25.7Fiscal year 2019Operating cash flow−93.4Capital expenditure−0.3Free cash flow−93.7Fiscal year 2020Operating cash flow−57.9Capital expenditure−0.8Free cash flow−58.7Fiscal year 2021Operating cash flow−33.4Capital expenditure−0.4Free cash flow−33.8Fiscal year 2022Operating cash flow−84.9Capital expenditure−1.6Free cash flow−86.5Fiscal year 2023Operating cash flow−34.0Capital expenditure−0.5Free cash flow−34.5Fiscal year 2024Operating cash flow−18.0Capital expenditure−1.5Free cash flow−19.5Fiscal year 2025Operating cash flow−42.3Capital expenditure−3.4Free cash flow−45.7
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −13.2 −25.7 −93.4 −57.9 −33.4 −84.9 −34.0 −18.0 −42.3
Capital expenditure 0.0 −0.0 −0.3 −0.8 −0.4 −1.6 −0.5 −1.5 −3.4
Free cash flow −13.2 −25.7 −93.7 −58.7 −33.8 −86.5 −34.5 −19.5 −45.7
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash0.0Shareholders’ equity−75.5Fiscal year 2018Cash93.2Total debt0.0Net cash (debt)93.2Shareholders’ equity84.4Debt to equity0.00Fiscal year 2019Cash109.9Total debt73.5Net cash (debt)36.4Shareholders’ equity79.5Debt to equity0.93Fiscal year 2020Cash102.6Shareholders’ equity−73.0Fiscal year 2021Cash146.3Total debt71.2Net cash (debt)75.0Shareholders’ equity81.9Debt to equity0.87Fiscal year 2022Cash53.9Total debt71.9Net cash (debt)−18.0Shareholders’ equity18.5Debt to equity3.89Fiscal year 2023Cash62.8Total debt120.4Net cash (debt)−57.5Shareholders’ equity−20.7Fiscal year 2024Cash87.0Total debt121.5Net cash (debt)−34.6Shareholders’ equity5.5Debt to equity22.00Fiscal year 2025Cash53.8Total debt146.1Net cash (debt)−92.3Shareholders’ equity−23.1
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.0 93.2 109.9 102.6 146.3 53.9 62.8 87.0 53.8
Total debt n/a 0.0 73.5 n/a 71.2 71.9 120.4 121.5 146.1
Net cash (debt) n/a 93.2 36.4 n/a 75.0 −18.0 −57.5 −34.6 −92.3
Shareholders’ equity −75.5 84.4 79.5 −73.0 81.9 18.5 −20.7 5.5 −23.1
Debt to equity n/a 0.00 0.93 n/a 0.87 3.89 n/a 22.00 n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−13.2 −25.7 −93.4 −57.9 −33.4 −84.9 −34.0 −18.0 −42.3
Growth
0.2 0.0 4.1 7.0 5.6 3.7 5.1 5.3 7.5
Investment
0.0 −0.0 −0.3 −0.8 −0.4 −1.6 −0.5 −1.5 −3.4
calc −13.2 −25.7 −93.7 −58.7 −33.8 −86.5 −34.5 −19.5 −45.7
Growth
calc n/a n/a n/a −1.74 −0.68 −1.54 −0.61 −0.31 −0.71
0.0 −0.0 −23.4 12.2 4.0 −2.9 −1.6 −4.8 −8.5
Financing
13.0 118.8 133.5 38.3 73.1 −4.1 44.6 47.4 17.3

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.